Heidi Health, an Australian healthtech company focused on clinical artificial intelligence, is finalizing a novel compute-for-equity arrangement with Victoria's state-backed innovation agency. The deal, which would be the first of its kind in Australia, aims to reduce the company's substantial AI computing costs while giving the government an ownership stake. It follows Heidi Health's recent valuation of A$1.26 billion and a US$100 million funding round led by Blackbird with participation from General Catalyst.
A New Model for Subsidized Compute
The proposed agreement involves Innovation Victoria, AI infrastructure builder ResetData, and Heidi Health as the foundational partners. Under ResetData's Australian AI Growth Program, select organizations and government departments help secure compute capacity and provide subsidized access to startups. The parties have signed a heads of agreement and expect to finalize the transaction within days, though the equity stake value has not been disclosed.
Government Validation and Company Response
ResetData co-founder and co-CEO Marcel Zalloua described the partnership as a meaningful validation of the program's goals. The program was developed with Nvidia and follows Innovation Victoria's September collaboration plans with the chipmaker's local cloud partners. Heidi Health's spokesperson added that innovative funding structures can remove a significant barrier to growth and strengthen Victoria's AI industry.
International Precedent and Strategic Value
The compute-for-equity model has already gained traction outside Australia. OpenAI popularized a similar offer to Y Combinator founders in 2026, and Nasdaq-listed CoreWeave launched a venture arm with the same structure in September 2025. For Heidi Health, the agentic platform launched last month is materially more compute-intensive than its predecessor, so discounted infrastructure access could improve unit economics.
Public Investment Debate
Despite that logic, the proposal has prompted criticism. Some commentators argue that Victoria is taking equity risk in a company already valued above one billion dollars while the state has limited fiscal flexibility. They question whether a state agency is well positioned to evaluate such a fast-moving and complex AI investment.
Competitive Pressures
Heidi Health is not operating in a protected market. Microsoft, Google, Epic, and a growing list of purpose-built clinical AI companies are all moving into the same space. The company currently benefits from clinician adoption and product velocity, but analysts say those advantages will need to prove durable in a highly contested sector.
Geographic and Valuation Concerns
Some observers also point to a geographic mismatch in the arrangement. Most of Heidi Health's customers are clinicians across Australia and internationally, so the benefits may not concentrate in Victoria. Additionally, the company's last funding round reportedly attracted no new US-based investors, a fact some market participants interpret as a cautionary signal about current valuation levels.
Sector Volatility
The Heidi Health announcement also coincides with broader volatility in Australian AI infrastructure. Data center builder Firmus has faced scrutiny over its plans for an ASX listing, with fund managers noting that 97% of promised capacity has not been built. Heidi is not directly comparable because it has an existing product, users, and revenue, but the timing highlights how quickly sentiment in the sector can shift.
The proposed compute-for-equity agreement between Heidi Health and Innovation Victoria represents a potential first for Australia and an attempt to address rising AI costs through public-private partnership. Supporters see it as a pragmatic way to keep high-growth startups local, while critics question the risk appetite of a state government entering late-stage technology investment. With final details still pending, the deal will be closely watched as a test case for government involvement in AI infrastructure.
Source: Capitalbrief